Botulinum toxin treatment of occupational and focal hand dystonia

Movement Disorders

Volumn 19, Issue SUPPL. 8, 2004, Pages

  Karp, Barbara Illowsky ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Botulinum toxin writer's cramp dystonias injection focal hand dystonia

Indexed keywords

BACTERIAL TOXIN; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN F; UNCLASSIFIED DRUG; ANTIPARKINSON AGENT;

ANTIBODY RESPONSE; ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSTONIA; ELECTROMYOGRAPHY; HAND DISEASE; HAND MUSCLE; HUMAN; MUSCLE CRAMP; OCCUPATIONAL DISEASE; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION; WRITING; REVIEW; TREATMENT OUTCOME;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DYSTONIC DISORDERS; ELECTROMYOGRAPHY; HUMANS; OCCUPATIONAL DISEASES; TREATMENT OUTCOME;

EID: 3242784092     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20025     Document Type: Article

References (31)

1. Ramazzini B. Diseases of scribes and notaries. In: Diseases of workers. New York: Hafner Publishing Company; 1713. p 421-425.
2. Gowers WR. A manual of diseases of the nervous system. American ed. Philadelphia: P. Blakiston, Son & Co; 1888.
3. Solly S. Scrivener's palsy, or the paralysis of writers. Lancet 1864;2:709-711.
4. Marsden CD, Sheehy MP. Writer's cramp. TINS 1990;13:148-153.
5. Jankovic J, Van Der Linden C. Dystonia and tremor induced by peripheral trauma: predisposing factors. J Neurol Neurosurg Psychiatry 1988;51:1512-1519.
6. Waddy HM, Fletcher NA, Harding AE, Marsden CD. A genetic study of idiopathic focal dystonias. Ann Neurol 1991;29:320-324.
7. Friedman JR, Klein C, Leung J, Woodward H, Ozelius LJ, Breakefield XO, et al. The GAG deletion of the DYT1 gene is infrequent in musicians with focal dystonia. Neurology 2000;55:1417-1418.
8. Kamm C, Naumann M, Mueller J, Mai N, Riedel L, Wissel J, et al. The DYT1 GAG deletion is infrequent in sporadic and familial writer' s cramp. Mov Disord 2000;15:1238-1241.
9. The Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. J Neurol 2000;247:787-792.
10. Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ. Epidemiology of focal and generalized dystonia in Rochester, Minn. Mov Disord 1988;3:188-194.
11. Pitner MA. Pathophysiology of overuse injuries in the hand and wrist. Hand Clin 1990;6:355-364.
12. Ranney D. Work-related chronic injuries of the forearm and hand: their specific diagnosis and management. Ergonomics 1993;36: 871-880.
13. Charness ME, Ross MH, Shefner JM. Ulnar neuropathy and dystonic flexion of the fourth and fifth digits: clinical correlation in musicians. Muscle Nerve 1996;19:431-437.
14. Cohen LG, Hallett M. Hand cramps: clinical features and electromyographic patterns in a focal dystonia. Neurology 1988;38:1005-1012.
15. Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD. The pathophysiology of primary dystonia. Brain 1998;121:1195-1212.
16. Bara-Jimenez W, Catalan MJ, Hallett M, Gerloff C. Abnormal somatosensory homunculus in dystonia of the hand. Neurology 1998;44:828-831.
17. Bara-Jimenez W, Shelton P, Sanger TD, Hallett M. Sensory discrimination capabilities in patients with focal hand dystonia. Ann Neurol 2000;47:377-380.
18. Chen R, Wassermann EM, Canos M, Hallett M. Impaired inhibition in writer's cramp during voluntary muscle activation. Neurology 1997;49:1054-1059.
19. Farmer SF, Sheehan GL, Mayston MJ, Rothwell JC, Marsden CD, Conway BA, et al. Abnormal motor unit synchronization of antagonist muscles underlies pathological co-contraction in upper limb dystonia. Brain 1998;121:801-814.
20. Gilio F, Curra A, Lorenzano C, Modugno N, Manfredi M, Berardelli A. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol 2000;48:20-26.
21. Nordstrom MA, Butler SL. Reduced intracortical inhibition and facilitation of corticospinal neurons in musicians. Exp Brain Res 2002;144:336-342.
22. Molloy FM, Shill HA, Kaelin-Lang A, Karp BI. Accuracy of muscle localization without EMG: implications for treatment of limb dystonia. Neurology 2002;58:805-807.
23. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990; 53:633-639.
24. Cohen LG, Hallett M, Geller BD, Hochberg FH. Treatment of focal dystonias of the hand with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1989;52:355-363.
25. Lees AJ, Turjanski N, Rivest J, Whurr R, Lorch M, Brookes G. Treatment of cervical dystonia, hand spasms and laryngeal dystonia with botulinum toxin. J Neurol 1992;239:1-4.
26. Poungvarin N. Writer's cramp: the experience with botulinum toxin injections in 25 patients. J Med Assoc Thai 1991;74:239-247.
27. Karp BI, Cohen LG, Cole R, Grill S, Lou JS, Hallett M. Long-term botulinum toxin treatment of focal hand dystonia. Neurology 1994; 44:70-76.
28. Chen R, Karp BI, Hallett M. Botulinum toxin type F for treatment of dystonia: long-term experience. Neurology 1998;51:1494-1496.
29. Karp BI, Cole RA, Cohen LG, Grill S, Lou JS, Hallett M. Long-term botulinum toxin treatment of focal hand dystonia. Neurology 1994;44:70-76.
30. Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O'Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 1999 53:1431-1438.
31. Dressler D, Bigalke H, Benecke R. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure. Neurology 2003;60(Suppl. 1):A465-A466.